Optimal approach in early breast cancer: Radiation therapy

European Journal of Cancer, Supplement

Volumn 11, Issue 2, 2013, Pages 27-36

  Poortmans, Philip ^a  

^a Institute Verbeeten   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST RECONSTRUCTION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CONFERENCE PAPER; EARLY CANCER; INTRADUCTAL CARCINOMA; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REGIONAL PERFUSION;

EID: 84884941790     PISSN: 13596349     EISSN: 18781217     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2013.07.028     Document Type: Conference Paper

References (79)

1. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
2. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
3. Fourquet A., Stoppa-Lyonnet D., Kirova Y.M., Sigal-Zafrani B., Asselain B. Familial breast cancer: clinical response to induction chemotherapy or radiotherapy related to brca1/2 mutations status. Am J Clin Oncol 2009, 32:127-131.
4. Pierce L.J., Phillips K.A., Griffith K.A., et al. Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat 2010, 121:389-398.
5. Clarke M., Collins R., Darby S., et al. For the Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
6. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004, 351:971-977.
7. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25:3259-3265.
8. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000, 180:299-304.
9. Litière S., Werutsky G., Fentiman I.S., et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012, 13:412-419.
10. Romestaing P., Lehingue Y., Carrie C., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997, 15:963-968.
11. Polgár C., Fodor J., Orosz Z., et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol 2002, 178:615-623.
12. Antonini N., Jones H., Horiot J.C., et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC Trial 22881-10882. Radiother Oncol 2007, 82:265-271.
13. Collette S., Collette L., Budiharto T., et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC trial 22881-10882 "boost versus no boost". Eur J Cancer 2008, 44:2587-2599.
14. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2d radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007, 82:254-2564.
15. Van Werkhoven E., Hart G., van Tinteren H., et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011, 100:101-107.
16. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
17. Offersen B.V., Overgaard M., Kroman N., Overgaard J. Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 2009, 90:1-13.
18. Mannino M., Yarnold J. Accelerated partial breast irradiation trials: diversity in rationale and design. Radiother Oncol 2009, 91:16-22.
19. Bartelink H., Bourgier C., Elkhuizen P. Has partial breast irradiation by IORT or brachytherapy been prematurely introduced into the clinic?. Radiother Oncol 2012, 104:139-142.
20. van der Sangen M.J., van de Wiel F.M., Poortmans P.M., et al. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤40 years. Breast Cancer Res Treat 2011, 127:207-215.
21. Bantema-Joppe E.J., de Munck L., Visser O., et al. Early-stage young breast cancer patients: impact of local treatment on survival. Int J Radiat Oncol Biol Phys 2011, 81:e553-e559.
22. Dunne C., Burke J.P., Morrow M., Kell M.R. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009, 27:1615-1620.
23. Correa C., McGale P., Taylor C., et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010, 41:162-177.
24. Omlin A., Amichetti M., Azria D., et al. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006, 7:652-656.
25. Katz A., Buchholz T.A., Thames H., et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys 2001, 50:397-403.
26. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005, 97:116-126.
27. Buchholz T.A., Tucker S.L., Masullo L., et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 2002, 20:17-23.
28. Strom E.A., Woodward W.A., Katz A., et al. Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:1508-1513.
29. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001, 19:1688-1697.
30. Overgaard M., Nielsen H.M., Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the dbcg 82 b&c randomized trials. Radiother Oncol 2007, 82:247-253.
31. Kunkler I. Adjuvant chest wall radiotherapy for breast cancer: Black, white and shades of grey. Eur J Surg Oncol 2010, 36:331-334.
32. Wright J.L., Cordeiro P.G., Ben-Porat L., et al. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: treatment intervals and clinical outcomes. Int J Radiat Oncol Biol Phys 2008, 70:43-50.
33. Nahabedian M.Y., Momen B. The impact of breast reconstruction on the oncologic efficacy of radiation therapy: a retrospective analysis. Ann Plast Surg 2008, 60:244-250.
34. Ho A., Cordeiro P., Disa J., et al. Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation. Cancer 2012, 118:2552-2559.
35. Barry M., Kell M.R. Radiotherapy and breast reconstruction: a meta-analysis. Breast Cancer Res Treat 2011, 127:15-22.
36. Nava M.B., Pennati A.E., Lozza L., et al. Outcome of different timings of radiotherapy in implant-based breast reconstructions. Plast Reconstr Surg 2011, 128:353-359.
37. Motwani S.B., Strom E.A., Schechter N.R., et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006, 66:76-82.
38. Massabeau C., Fournier-Bidoz N., Wakil G., et al. Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment?. Med Dosim 2012, 37:425-431.
39. Percec I., Bucky L.P. Successful prosthetic breast reconstruction after radiation therapy. Ann Plast Surg 2008, 60:527-531.
40. Spear S.L., Boehmler J.H., Bogue D.P., Mafi A.A. Options in reconstructing the irradiated breast. Plast Reconstr Surg 2008, 122:379-388.
41. Hvilsom G.B., Hölmich L.R., Steding-Jessen M., et al. Delayed breast implant reconstruction: is radiation therapy associated with capsular contracture or reoperations?. Ann Plast Surg 2012, 68:246-252.
42. Brooks S., Djohan R., Tendulkar R., et al. Risk factors for complications of radiation therapy on tissue expander breast reconstructions. Breast J 2012, 18:28-34.
43. Momoh A.O., Colakoglu S., de Blacam C., et al. Delayed autologous breast reconstruction after postmastectomy radiation therapy: is there an optimal time?. Ann Plast Surg 2012, 69:389-393.
44. Baumann D.P., Crosby M.A., Selber J.C., et al. Optimal timing of delayed free lower abdominal flap breast reconstruction after postmastectomy radiation therapy. Plast Reconstr Surg 2011, 127:1100-1106.
45. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S., McGale P., Correa C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378:1707-1716.
46. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol 2007, 84:84-101.
47. Veronesi U., Luini A., Galimberti V., et al. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990, 16:127-133.
48. Shahar K.H., Buchholz T.A., Delpassand E., et al. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 2005, 103:1323-1329.
49. Pinero-Madrona A., Nicolas-Ruiz F., Galindo-Fernandez P.J., et al. Technical features of interest in lymphatic basin localization in breast cancer sentinel lymph node biopsy. Cir Esp 2007, 81:264-268.
50. Reed V.K., Cavalcanti J.L., Strom E.A., et al. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 2008, 71:435-440.
51. Giuliano A.E., Hunt K.K., Ballman K.V., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011, 9:569-575.
52. Darby S.C., Ewertz M., McGale P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013, 368:987-998.
53. Remouchamps V.M., Vicini F.A., Sharpe M.B., et al. Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation. Int J Radiat Oncol Biol Phys 2003, 55:392-406.
54. Keall P.J., Mageras G.S., Balter J.M., et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys 2006, 33:3874-3900.
55. Moran J.M., Balter J.M., Ben-David M.A., et al. Short-term displacement and reproducibility of the breast and nodal targets under active breathing control. Int J Radiat Oncol Biol Phys 2007, 68:541-546.
56. Liengsawangwong R., Yu T.K., Sun T.L., et al. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 2007, 69:711-715.
57. Kirova Y.M., Campana F., Fournier-Bidoz N., et al. Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy. Int J Radiat Oncol Biol Phys 2007, 69:1139-1144.
58. Feng M., Moran J.M., Koelling T., et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 2011, 79:10-18.
59. Khatcheressian J.L., Wolff A.C., Smith T.J., et al. American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006, 24:5091-5097.
60. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005, 75:9-17.
61. Schubert L.K., Gondi V., Sengbusch E., et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol 2011, 100:241-246.
62. Smith W., Menon G., Wolfe N., et al. IMRT for the breast: a comparison of tangential planning techniques. Phys Med Biol 2010, 55:1231-1241.
63. Nicolini G., Vanetti E., Clivio A., et al. Pre-clinical evaluation of respiratory-gated delivery of volumetric modulated arc therapy with RapidArc. Phys Med Biol 2010, 55:N347-N357.
64. Van Mourik A., van Kranen S., den Hollander S., et al. Effects of setup errors and shape changes on breast radiotherapy. Int J Radiat Biol Phys 2011, 79:1557-1564.
65. START Trialists' Group, Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341.
66. START Trialists' Group, Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371:1098-1107.
67. Whelan T.J., Pignol J.P., Levine M.N., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362:513-520.
68. van Asselen B., Schwarz M., van Vliet-Vroegindeweij C., et al. Intensity-modulated radiotherapy of breast cancer using direct aperture optimization. Radiother Oncol 2006, 79:162-169.
69. Al Uwini S., Antonini N., Poortmans P.M., et al. The influence of the use of ct-planning on the irradiated boost volume in breast conserving treatment. Radiother Oncol 2009, 93:87-93.
70. van der Laan H.P., Dolsma W.V., Maduro J.H., et al. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68:1018-1023.
71. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
72. van Mourik A.M., Elkhuizen P.H., Minkema D., et al. Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol 2010, 94:286-291.
73. Li X.A., Tai A., Arthur D.W., et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys 2009, 73:944-951.
74. Bloom E.S., Poortmans P., Aznar M., Buchholz T.A., Strom E.A. Breast cancer. Intact and post mastectomy. Technical basis of radiation therapy 2012, 641-684. Springer-Verlag Berlin and Heidelberg Gmbh & Co. S.H. Levitt, J.A. Purdy, C.A. Perez, P. Poortmans (Eds.).
75. Straver M.E., Meijnen P., van Tienhoven G., et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 2010, 17:1854-1861.
76. Campbell H.E., Epstein D., Bloomfield D., et al. The cost-effectiveness of adjuvant chemotherapy for early breast cancer: a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. Eur J Cancer 2011, 47:2517-2530.
77. Punglia R.S., Morrow M., Winer E.P., Harris J.R. Local therapy and survival in breast cancer. N Engl J Med 2007, 356:2399-2405.
78. Matzinger O., Heimsoth I., Poortmans P., et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010, 49:24-34.
79. FAST Trialists group, Agrawal R.K., Alhasso A., Barrett-Lee P.J., et al. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 2011, 100:93-100.